HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Gregory Bociek Selected Research

R Gregory Bociek Research Topics

Disease

6Hodgkin Disease (Hodgkin's Disease)
01/2020 - 12/2011
5Lymphoma (Lymphomas)
01/2023 - 02/2005
4Neoplasms (Cancer)
04/2024 - 12/2007
4Hematologic Neoplasms (Hematological Malignancy)
11/2016 - 09/2003
3Burkitt Lymphoma (Burkitt's Lymphoma)
11/2018 - 06/2005
3Thrombocytopenia (Thrombopenia)
11/2016 - 03/2007
3Tumor Lysis Syndrome
03/2015 - 03/2007
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2012 - 10/2008
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2023 - 06/2011
2Leukemia
03/2015 - 07/2014
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
09/2007 - 03/2007
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/2022
1Pain (Aches)
01/2022
1Pericarditis
01/2016
1Pericardial Effusion
01/2016
1B-Cell Lymphoma (Lymphoma, B Cell)
11/2015
1Hypersensitivity (Allergy)
10/2015
1Anaphylaxis (Anaphylactic Shock)
10/2015
1Hypotension (Low Blood Pressure)
03/2015
1Primary Myelofibrosis (Myelosclerosis)
03/2015
1Anemia
03/2015
1Myeloproliferative Disorders (Myeloproliferative Disorder)
03/2015
1Essential Thrombocythemia
03/2015
1Disseminated Intravascular Coagulation
03/2015
1Leukocytosis (Pleocytosis)
03/2015
1Fever (Fevers)
03/2015
1Philadelphia Chromosome
07/2014
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2014
1Disease Resistance
09/2007
1Disease Progression
09/2007
1Second Primary Neoplasms (Neoplasms, Second)
03/2007
1Opportunistic Infections (Opportunistic Infection)
03/2007
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2005

Drug/Important Bio-Agent (IBA)

3Brentuximab VedotinIBA
01/2020 - 10/2015
3Rituximab (Mabthera)FDA Link
11/2015 - 10/2008
2Bendamustine HydrochlorideFDA Link
01/2020 - 01/2018
2Histone Deacetylase InhibitorsIBA
01/2016 - 12/2011
2Monoclonal AntibodiesIBA
10/2015 - 02/2008
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2008 - 03/2007
1ibrutinibIBA
04/2024
1Lenalidomide (CC 5013)FDA Link
01/2023
1carfilzomibIBA
02/2022
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
11/2016
1Heparin (Liquaemin)FDA LinkGeneric
11/2016
1Warfarin (Coumadin)FDA LinkGeneric
11/2016
1entinostat (MS 275)IBA
01/2016
1AntibodiesIBA
01/2016
1Immunoconjugates (Immunoconjugate)IBA
01/2016
1Protein Isoforms (Isoforms)IBA
01/2016
1ruxolitinibIBA
03/2015
1Cytarabine (Cytosar-U)FDA LinkGeneric
07/2014
1AnthracyclinesIBA
07/2014
1Imatinib Mesylate (Gleevec)FDA Link
07/2014
1mocetinostatIBA
12/2011
1Prednisone (Sone)FDA LinkGeneric
11/2008
1Vincristine (Oncovin)FDA LinkGeneric
11/2008
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2008
1CytokinesIBA
03/2007
1oblimersen (G3139)IBA
03/2007
1Proteins (Proteins, Gene)FDA Link
03/2007
1fludarabineIBA
03/2007
1VaccinesIBA
02/2005
1Proteasome InhibitorsIBA
02/2005
1HLA Antigens (Human Leukocyte Antigens)IBA
09/2003

Therapy/Procedure

11Therapeutics
04/2024 - 02/2005
7Drug Therapy (Chemotherapy)
01/2023 - 02/2005
5Stem Cell Transplantation
01/2023 - 12/2011
4Hematopoietic Stem Cell Transplantation
07/2015 - 12/2007
2Radiotherapy
11/2015 - 02/2005
1Transplantation
01/2023
1Length of Stay
01/2022
1Salvage Therapy
01/2020
1Vena Cava Filters (Inferior Vena Cava Filter)
11/2016
1Immunotherapy
02/2008
1Aftercare (After-Treatment)
02/2005